Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immuron Ltd (IMRN)
NASDAQ:IMRN
Immuron (IMRN) Stock Price & Analysis
172 Followers
IMRN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.48 - $5.96
Previous Close$2.31
Volume26.25K
Average Volume (3M)964.95K
Market Cap
$14.63M
Enterprise Value-$2.53M
Total Cash (Recent Filing)AU$17.16M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)-5.1
Beta0.39
Next Earnings
Aug 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding5,694,959
10 Day Avg. Volume27,084
30 Day Avg. Volume964,954
Standard Deviation0.38
R-Squared0.04
Alpha0.00826
Financial Highlights & Ratios
Price to Book (P/B)0.70
Price to Sales (P/S)7.73
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Immuron News
PremiumPress Releases
Immuron to host Live Virtual Event
PremiumPress Releases
Immuron Travelan® sales continued strong growth
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
IMRN FAQ
What was Immuron Ltd’s price range in the past 12 months?
Immuron Ltd lowest stock price was $1.48 and its highest was $5.96 in the past 12 months.
What is Immuron Ltd’s market cap?
Currently, no data Available
When is Immuron Ltd’s upcoming earnings report date?
Immuron Ltd’s upcoming earnings report date is Aug 30, 2024 which is in 127 days.
How were Immuron Ltd’s earnings last quarter?
Immuron Ltd released its earnings results on Feb 28, 2024. The company reported -$0.238 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.238.
Is Immuron Ltd overvalued?
According to Wall Street analysts Immuron Ltd’s price is currently Overvalued.
Does Immuron Ltd pay dividends?
Immuron Ltd does not currently pay dividends.
What is Immuron Ltd’s EPS estimate?
Immuron Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immuron Ltd have?
Immuron Ltd has 5,699,959 shares outstanding.
What happened to Immuron Ltd’s price movement after its last earnings report?
Immuron Ltd reported an EPS of -$0.238 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.705%.
Which hedge fund is a major shareholder of Immuron Ltd?
Currently, no hedge funds are holding shares in IMRN
---
Immuron Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.71%
12-Months-Change
Fundamentals
Return on Equity
-19.52%
Trailing 12-Months
Asset Growth
-13.40%
Trailing 12-Months
Company Description
Immuron Ltd
Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States. The HyperImmune Products segment comprises of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.
---
Technical Analysis
---